Centurium Capital and Cedarlake Capital led the $187m round in Iluvatar CoreX.

Centurium Capital, a private equity firm specializing in investments in the healthcare and consumer sectors in China, and Cedarlake Capital, a global investment platform, led the $187m round in Iluvatar CoreX, a high-performance computing solutions provider. Investors Gortune Investment, China Unicom Capital also participated in the round. With this funding round from private equity and venture capital investors, Iluvatar CoreX established itself in the semiconductor sector as Chinese players get more attention.